Premium
O1‐10‐01: PRECLINICAL PROFILES OF DRUG CANDIDATES PROMOTING O‐LINKED GLYCOSYLATION OF TAU FOR THE TREATMENT OF ALZHEIMER'S DISEASE AND TAUOPATHIES
Author(s) -
Quattropani Anna,
Beher Dirk,
Nény Maud,
Ousson Solenne,
Hantson Jennifer,
Sand Astrid,
Permanne Bruno,
Wiessner Christoph
Publication year - 2014
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2014.04.110
Subject(s) - tauopathy , neurodegeneration , frontotemporal dementia , chemistry , drug discovery , threonine , serine , drug , parkinsonism , dementia , in vivo , drug development , tau protein , pharmacology , neuroscience , biochemistry , phosphorylation , alzheimer's disease , disease , biology , medicine , genetics